Regulatory and clinical trials
HIRUZ, the Health Innovation and Research Center of Ghent University Hospital, provides support with the submission and registration, monitoring and project management of clinical trials.
D.R.U.G. (the drug research unit of Ghent University Hospital) conducts Phase 0 – I – II clinical trials evaluating new candidate drugs, according to the ICH/GCP and local, European and international legislation.
Levi Hoste is a general pediatrician employed at the Ghent University Hospital. He has a background in clinical immunology. He coordinates hospital activities on pediatric drug research including the pediatric clinical trial unit Safepedrug Clinical Trial Unit (SPD-CTU) as part of the Drug Research Unit Gent (D.R.U.G.) and the Belgian Pediatric Clinical Research Network (BPCRN), national hub of the conect4children (c4c) consortium.
Prof. Wim Ceelen
Wim Ceelen is a surgical oncologist with an interest in advanced or recurrent GI cancer, soft tissue retroperitoneal cancers, ovarian cancer, and peritoneal metastasis. He Ieads lead the Experimental Surgery lab at Ghent University, which has between 4 and 8 PhD students, one postdoc, and 4 support staff. We perform clinical, translational, and basic research in the fields of intraperitoneal drug delivery, novel treatments of peritoneal metastasis, biophysical properties of cancer tissue, and lymphatic metastasis in colon cancer.
Prof. Frank Speleman
Frank Speleman is professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences. His main focus is the study of perturbed gene regulatory processes in paediatric cancer, more specifically neuroblastoma and T-ALL.
Prof. Stan Monstrey
Former Chairman of the Department of Plastic Surgery and Burn Center at the Ghent University Hospital.
Prof. Jolanda van Hengel
Prof. Jolanda van Hengel is heading the medical cell biology group. Her group focuses on the in vitro engineering of functional myocardium that mimics human heart tissue for analysis of myocardial function. Also her group tries to obtain a suitable stem cell type for in vitro meat production.TISSUE ENGINEERING RESEARCH, CELL THERAPY, GENE THERAPY, ORGANOIDS AND ORGANONCHIP, MICROFLUIDICS AND LABONCHIP, CELLS, 3D CULTURES AND ORGANOIDS, BIOMATERIALS AND PROCESSING, ANALYTIC TOOLS IN GENE, CELL AND TISSUE ENGINEERING, GENES & NANODELIVERY SYSTEMS, REGULATORY AND CLINICAL TRIALS, GMP MANUFACTURING
Prof. Els De Leenheer
Prof. Kristl Vonck
Kristl Vonck is Head of the Department ‘Head and Skin’ at Ghent University and full professor of neurology at the department of Neurology at Ghent University Hospital. Research interests include epilepsy, neuromodulation, bioelectronic medicine and neurophysiological home-monitoring of neurological disorders and is performed at the 4brain lab.
Prof. Filip Van Nieuwerburgh
Filip Van Nieuwerburgh heads the UGent Next Generation Sequencing core facility NXTGNT, focusing on transcriptomics, (epi)genomics and bioinformatics.
Dr. Frederic Acke
Frederic Acke is an otorhinolaryngologist with a PhD on genetic hearing loss. His main research focus is the exploration of mechanisms and innovative treatment strategies, including gene therapy, for inner ear disorders.
Dr. Bernard Depypere
Bernard Depypere, MD received his medical degree from the University of Ghent. He started his training to become Plastic & Reconstructive Surgeon in 2013 and is now chair member at the department of Prof. Dr. Blondeel in Ghent.
Prof. Phillip Blondeel
Phillip Blondeel is full Professor of Plastic Surgery at the Ghent University, Belgium. He is the head of the Department of Plastic and Reconstructive Surgery and at the Burn Center of the Ghent University Hospital.